Connection

Taixing Cui to Tumor Necrosis Factor-alpha

This is a "connection" page, showing publications Taixing Cui has written about Tumor Necrosis Factor-alpha.
Connection Strength

0.527
  1. Ubiquitin carboxyl terminal hydrolase L1 negatively regulates TNFalpha-mediated vascular smooth muscle cell proliferation via suppressing ERK activation. Biochem Biophys Res Commun. 2010 Jan 01; 391(1):852-6.
    View in: PubMed
    Score: 0.273
  2. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells. Biochem Biophys Res Commun. 2012 Mar 30; 420(1):78-83.
    View in: PubMed
    Score: 0.080
  3. An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes. J Ethnopharmacol. 2010 Jul 20; 130(2):222-30.
    View in: PubMed
    Score: 0.070
  4. An emerging role of deubiquitinating enzyme cylindromatosis (CYLD) in the tubulointerstitial inflammation of IgA nephropathy. Biochem Biophys Res Commun. 2009 Dec 11; 390(2):307-12.
    View in: PubMed
    Score: 0.067
  5. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation. Arterioscler Thromb Vasc Biol. 2007 Oct; 27(10):2184-90.
    View in: PubMed
    Score: 0.015
  6. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension. 2004 May; 43(5):1003-10.
    View in: PubMed
    Score: 0.011
  7. Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury. Hypertension. 2003 Oct; 42(4):542-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.